|
Sources: Pfizer Eyeing MediGene as Takeover Target
May
14, 2008--According to
industry sources, Pfizer is exploring acquisition possibilities in
the German biotech sector and has held talks with MediGene’s
management. MediGene has a prostate cancer drug and a genital
warts treatment on the market, plus a promising new product
pipeline. MediGene believes its pancreatic cancer drug candidate,
Endotag, is poised to become a potential blockbuster. Both
companies declined to comment on the prospect. Reuters
|
